Balance Sheet Data

Alexion Pharmaceuticals, Inc. (ALXN)

$182.5

0.00 (0.00%)

Year
A/P
2016
Actual
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
Total Cash 1,2931,474.101,563.802,749.502,999.403,247.573,847.654,558.615,400.936,398.90
Total Cash (%)
Account Receivables 650726.50922.301,243.201,409.301,610.701,908.322,260.932,678.703,173.66
Account Receivables (%)
Inventories 375460.40472.50627.60775.70890.531,055.081,250.041,481.021,754.67
Inventories (%)
Accounts Payable 6470.8074.4074118.60133.85158.59187.89222.61263.74
Accounts Payable (%)
Capital Expenditure -333-357.30-213-170.70-106.70-448.65-531.55-629.77-746.14-884.01
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.